#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	531	14226	16S	1529	1529	99.93	16S.l15.c4.ctg.1	2199	644.5	0	.	n	.	0	C1450T	SNP	1450	1450	C	1721	1721	T	743	T	685	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	531	14226	16S	1529	1529	99.93	16S.l15.c4.ctg.1	2199	644.5	1	SNP	n	C1184T	0	.	.	1184	1184	C	1455	1455	C	844	C,G	782,1	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	26364	23S	2890	2890	99.93	23S.l15.c30.ctg.1	3670	716.9	0	.	n	.	0	T695C	SNP	695	695	T	1085	1085	C	811	C	745	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	26364	23S	2890	2890	99.93	23S.l15.c30.ctg.1	3670	716.9	0	.	n	.	0	T1971C	SNP	1971	1971	T	2361	2361	C	869	C	779	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	26364	23S	2890	2890	99.93	23S.l15.c30.ctg.1	3670	716.9	1	SNP	n	A2045G	0	.	.	2045	2045	A	2435	2435	A	840	A	785	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	531	26364	23S	2890	2890	99.93	23S.l15.c30.ctg.1	3670	716.9	1	SNP	n	C2597T	0	.	.	2597	2597	C	2987	2987	C	807	C	753	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
folP.WHO_F_01537c	folP.WHO_F_01537c	1	1	539	1888	folP	852	852	99.88	folP.l6.c4.ctg.1	1480	127.0	0	.	p	.	0	A204V	NONSYN	610	612	GCA	923	925	GTA	176;174;170	G;T;A	164;159;158	.	.
folP.WHO_F_01537c	folP.WHO_F_01537c	1	1	539	1888	folP	852	852	99.88	folP.l6.c4.ctg.1	1480	127.0	1	SNP	p	R228S	0	.	.	682	684	CGC	995	997	CGC	195;197;192	C;G;C	184;188;182	folP.WHO_F_01537c:1:1:R228S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	4842	gyrA	2751	2751	99.82	gyrA.l15.c17.ctg.1	3319	145.5	1	SNP	p	S91F	0	.	.	271	273	TCC	537	539	TCC	168;164;165	T;C;C	154;148;150	gyrA.WHO_F_00668c:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	4842	gyrA	2751	2751	99.82	gyrA.l15.c17.ctg.1	3319	145.5	1	SNP	p	D95N	0	.	.	283	285	GAC	549	551	GAC	152;152;152	G;A;C	134;135;135	gyrA.WHO_F_00668c:1:1:D95N:gyrA.95N:Resistance to fluoroquinolones	.
gyrA.WHO_F_00668c	gyrA.WHO_F_00668c	1	1	27	4842	gyrA	2751	2751	99.82	gyrA.l15.c17.ctg.1	3319	145.5	1	SNP	p	D95G	0	.	.	283	285	GAC	549	551	GAC	152;152;152	G;A;C	134;135;135	gyrA.WHO_F_00668c:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
mtrR.WHO_L_00489c	mtrR.WHO_L_00489c	1	1	27	1470	mtrR	633	633	99.68	mtrR.l15.c4.ctg.1	1307	112.4	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	744	mtrR_promoter	250	250	99.6	mtrR_promoter.l6.c30.ctg.1	905	81.8	0	.	n	.	0	G33.	DEL	33	33	G	319	319	G	152	G	140	.	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	539	4542	parC	2304	2304	99.74	parC.l6.c4.ctg.1	2860	158.2	0	.	p	.	0	V435A	NONSYN	1303	1305	GTG	1559	1561	GCA	177;177;177	G;C;A	158;161;159	.	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	539	4542	parC	2304	2304	99.74	parC.l6.c4.ctg.1	2860	158.2	0	.	p	.	0	V596I	NONSYN	1786	1788	GTT	2042	2044	ATT	205;204;203	A;T;T	190;191;191	.	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	539	4542	parC	2304	2304	99.74	parC.l6.c4.ctg.1	2860	158.2	0	.	p	.	0	V646A	NONSYN	1936	1938	GTG	2192	2194	GCG	201;202;202	G;C;G	180;177;182	.	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	539	4542	parC	2304	2304	99.74	parC.l6.c4.ctg.1	2860	158.2	1	SNP	p	D86N	0	.	.	256	258	GAC	512	514	GAC	177;178;178	G;A;C	161;155;160	parC.WHO_M_00204c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	539	4542	parC	2304	2304	99.74	parC.l6.c4.ctg.1	2860	158.2	1	SNP	p	S87W	0	.	.	259	261	AGT	515	517	AGT	179;175;175	A;G;T	159;156;155	parC.WHO_M_00204c:1:1:S87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	539	4542	parC	2304	2304	99.74	parC.l6.c4.ctg.1	2860	158.2	1	SNP	p	S87R	0	.	.	259	261	AGT	515	517	AGT	179;175;175	A;G;T	159;156;155	parC.WHO_M_00204c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	539	4542	parC	2304	2304	99.74	parC.l6.c4.ctg.1	2860	158.2	1	SNP	p	S87I	0	.	.	259	261	AGT	515	517	AGT	179;175;175	A;G;T	159;156;155	parC.WHO_M_00204c:1:1:S87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	539	4542	parC	2304	2304	99.74	parC.l6.c4.ctg.1	2860	158.2	1	SNP	p	S88P	0	.	.	262	264	TCC	518	520	TCC	177;176;181	T;C;C	156;156;160	parC.WHO_M_00204c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	539	3982	parE	1986	1986	99.85	parE.l6.c30.ctg.1	2730	145.4	0	.	p	.	0	V89A	NONSYN	265	267	GTC	669	671	GCC	172;170;171	G;C;C	156;160;156	.	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	539	3982	parE	1986	1986	99.85	parE.l6.c30.ctg.1	2730	145.4	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1632	1634	GGC	176;179;178	G;G,A;C	159;159,1;160	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.45.001	penA.45.001	1	1	27	3892	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2272	170.0	1	SNP	p	A311V	0	.	.	931	933	GCA	1253	1255	GCA	194;198;201	G;C;A	181;184;188	penA.45.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.45.001	penA.45.001	1	1	27	3892	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2272	170.0	1	SNP	p	I312M	0	.	.	934	936	ATC	1256	1258	ATC	206;205;205	A;T;C	192;189;190	penA.45.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.45.001	penA.45.001	1	1	27	3892	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2272	170.0	1	SNP	p	V316P	0	.	.	946	948	GTG	1268	1270	GTG	206;202;200	G;T;G	194;188;189	penA.45.001:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.45.001	penA.45.001	1	1	27	3892	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2272	170.0	1	SNP	p	V316T	0	.	.	946	948	GTG	1268	1270	GTG	206;202;200	G;T;G	194;188;189	penA.45.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.45.001	penA.45.001	1	1	27	3892	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2272	170.0	1	SNP	p	T483S	0	.	.	1447	1449	ACC	1769	1771	ACC	184;182;183	A;C;C	172;170;170	penA.45.001:1:1:T483S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.45.001	penA.45.001	1	1	27	3892	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2272	170.0	1	SNP	p	A501P	0	.	.	1501	1503	GCG	1823	1825	GCG	186;186;186	G;C;G	160;148;155	penA.45.001:1:1:A501P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.45.001	penA.45.001	1	1	27	3892	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2272	170.0	1	SNP	p	A501V	0	.	.	1501	1503	GCG	1823	1825	GCG	186;186;186	G;C;G	160;148;155	penA.45.001:1:1:A501V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.45.001	penA.45.001	1	1	27	3892	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2272	170.0	1	SNP	p	G542S	0	.	.	1624	1626	GGT	1946	1948	GGT	190;186;186	G;G;T	176;174;171	penA.45.001:1:1:G542S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.45.001	penA.45.001	1	1	27	3892	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2272	170.0	1	SNP	p	G545S	0	.	.	1633	1635	GGC	1955	1957	GGC	184;183;181	G;G;C	169;169;166	penA.45.001:1:1:G545S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.45.001	penA.45.001	1	1	27	3892	penA	1749	1749	100.0	penA.l15.c4.ctg.1	2272	170.0	1	SNP	p	P551S	0	.	.	1651	1653	CCG	1973	1975	CCG	181;187;189	C,G;C;G,C	119,1;146;136,1	penA.45.001:1:1:P551S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_F_00106	ponA.WHO_F_00106	1	1	539	5616	ponA	2397	2397	99.87	ponA.l15.c4.ctg.1	2969	188.3	0	.	p	.	0	A375T	NONSYN	1123	1125	GCG	1471	1473	ACG	222;222;225	A;C;G	199;206;207	.	.
ponA.WHO_F_00106	ponA.WHO_F_00106	1	1	539	5616	ponA	2397	2397	99.87	ponA.l15.c4.ctg.1	2969	188.3	1	SNP	p	L421P	0	.	.	1261	1263	CTG	1609	1611	CTG	197;198;198	C;T;G	178;180;178	ponA.WHO_F_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	1860	porA	1146	1146	99.65	porA.l6.c17.ctg.1	1525	120.1	0	.	p	.	0	S22G	NONSYN	64	66	AGC	257	259	GGC	114;113;115	G;G;C	106;103;105	.	.
porA.NCCP11945	porA.NCCP11945	1	0	531	1860	porA	1146	1146	99.65	porA.l6.c17.ctg.1	1525	120.1	0	.	p	.	0	M83fs	FSHIFT	247	247	A	439	439	C	134	C	119	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	2874	porB1b	1041	1041	96.18	porB1b.l15.c17.ctg.1	1548	184.5	0	.	p	.	0	T89S	NONSYN	265	267	ACC	621	623	AGC	240;239;242	A;G;C	217;220;222	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	2874	porB1b	1041	1041	96.18	porB1b.l15.c17.ctg.1	1548	184.5	0	.	p	.	0	.	MULTIPLE	358	359	AA	713	714	CG	207;207	C,T;G,T,A	193,1;194,1,1	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	2874	porB1b	1041	1041	96.18	porB1b.l15.c17.ctg.1	1548	184.5	0	.	p	.	0	.	MULTIPLE	361	362	GA	716	718	CAG	209;211;211	C;A;G	200;201;201	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	2874	porB1b	1041	1041	96.18	porB1b.l15.c17.ctg.1	1548	184.5	0	.	p	.	0	N122K	NONSYN	364	366	AAC	720	722	AAA	214;214;214	A;A;A	203;203;203	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	2874	porB1b	1041	1041	96.18	porB1b.l15.c17.ctg.1	1548	184.5	0	.	p	.	0	F131Y	NONSYN	391	393	TTT	747	749	TAT	228;227;227	T;A;T	211;207;208	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	2874	porB1b	1041	1041	96.18	porB1b.l15.c17.ctg.1	1548	184.5	0	.	p	.	0	N134E	NONSYN	400	402	AAT	756	758	GAG	223;222;222	G;A;G	204;201;202	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	2874	porB1b	1041	1041	96.18	porB1b.l15.c17.ctg.1	1548	184.5	0	.	p	.	0	V135F	NONSYN	403	405	GTG	759	761	TTT	224;227;224	T,C;T;T	198,1;204;202	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	2874	porB1b	1041	1041	96.18	porB1b.l15.c17.ctg.1	1548	184.5	0	.	p	.	0	G140K	NONSYN	418	420	GGA	774	776	AAA	229;231;232	A;A;A	207;208;211	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	2874	porB1b	1041	1041	96.18	porB1b.l15.c17.ctg.1	1548	184.5	0	.	p	.	0	K143E	NONSYN	427	429	AAA	783	785	GAA	231;233;239	G;A;A	208;208;216	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	2874	porB1b	1041	1041	96.18	porB1b.l15.c17.ctg.1	1548	184.5	0	.	p	.	0	V151A	NONSYN	451	453	GTA	807	809	GCA	240;240;239	G;C;A	220;219;216	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	2874	porB1b	1041	1041	96.18	porB1b.l15.c17.ctg.1	1548	184.5	0	.	p	.	0	Y212H	NONSYN	634	636	TAT	990	992	CAT	250;253;252	C;A;T	232;235;232	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	2874	porB1b	1041	1041	96.18	porB1b.l15.c17.ctg.1	1548	184.5	0	.	p	.	0	T213L	NONSYN	637	639	ACA	993	995	TTA	256;256;255	T;T;A	237;239;237	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	2874	porB1b	1041	1041	96.18	porB1b.l15.c17.ctg.1	1548	184.5	0	.	p	.	0	A244V	NONSYN	730	732	GCA	1086	1088	GTA	250;250;255	G;T;A	233;230;237	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	2874	porB1b	1041	1041	96.18	porB1b.l15.c17.ctg.1	1548	184.5	0	.	p	.	0	G253Q	NONSYN	757	759	GGA	1113	1115	CAA	223;218;214	C;A;A	208;206;203	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	2874	porB1b	1041	1041	96.18	porB1b.l15.c17.ctg.1	1548	184.5	0	.	p	.	0	.	INDELS	760	762	ACA	1117	1121	ATCAA	212;214;210;207;207	A;T;C;A;A	202;203;200;200;199	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	2874	porB1b	1041	1041	96.18	porB1b.l15.c17.ctg.1	1548	184.5	0	.	p	.	0	.	INDELS	763	764	TG	1124	1126	AGT	210;209;207	A;G;T	201;200;196	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	2874	porB1b	1041	1041	96.18	porB1b.l15.c17.ctg.1	1548	184.5	0	.	p	.	0	A257D	NONSYN	769	771	GCT	1131	1133	GAT	213;212;212	G;A;T	203;204;204	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	2874	porB1b	1041	1041	96.18	porB1b.l15.c17.ctg.1	1548	184.5	0	.	p	.	0	V270A	NONSYN	808	810	GTA	1170	1172	GCG	201;202;202	G;C;G	185;186;187	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	2874	porB1b	1041	1041	96.18	porB1b.l15.c17.ctg.1	1548	184.5	0	.	p	.	0	D292N	NONSYN	874	876	GAT	1236	1238	AAT	234;234;241	A,C,T;A;T	216,1,1;220;223	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	2874	porB1b	1041	1041	96.18	porB1b.l15.c17.ctg.1	1548	184.5	0	.	p	.	0	D293S	NONSYN	877	879	GAT	1239	1241	AGT	241;239;239	A;G;T	223;220;219	.	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	2874	porB1b	1041	1041	96.18	porB1b.l15.c17.ctg.1	1548	184.5	1	SNP	p	G120K	1	.	.	358	360	AAG	713	715	CGG	207;207;207	C,T;G,T,A;G	193,1;194,1,1;196	porB1b.WHO_M_02204c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	2874	porB1b	1041	1041	96.18	porB1b.l15.c17.ctg.1	1548	184.5	1	SNP	p	A121D	1	.	.	361	363	GAC	716	719	CGC	209;211;210	C;G;C	200;201;199	porB1b.WHO_M_02204c:1:1:A121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_M_02204c	porB1b.WHO_M_02204c	1	1	539	2874	porB1b	1041	1041	96.18	porB1b.l15.c17.ctg.1	1548	184.5	1	SNP	p	D121N	0	.	.	361	363	GAC	716	719	CGC	209;211;210	C;G;C	200;201;199	porB1b.WHO_M_02204c:1:1:D121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_F_02153c	rpoB.WHO_F_02153c	1	1	27	11580	rpoB	4179	4179	100.0	rpoB.l15.c4.ctg.1	4760	242.6	1	SNP	p	H553N	0	.	.	1657	1659	CAT	1928	1930	CAT	257;259;258	C;A;T	239;240;242	rpoB.WHO_F_02153c:1:1:H553N:rpoB.553N:H552N. High-level resistance to Rifampicin	.
rpsJ.WHO_F_02142c	rpsJ.WHO_F_02142c	1	1	27	1154	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	975	117.1	1	SNP	p	V57M	0	.	.	169	171	GTG	568	570	GTG	252;253;253	G;T;G	229;226;227	rpsJ.WHO_F_02142c:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
